Sagimet Biosciences Inc (SGMT) PT Raised to $49 at Canaccord

May 4, 2026 6:41 AM

Canaccord analyst Edward Nash raised the price target on Sagimet Biosciences Inc (NASDAQ: SGMT) to $49.00 (from $28.00) while maintaining a Buy rating.

No results found